Comparison of Neovascular Age-Related Macular Degeneration Populations in the United States
Age-related macular degeneration (AMD) is one of the leading causes of blindness in the United States in people who are 50 and older. The safety and efficacy of aflibercept for the treatment of late stage neovascular AMD (NAMD) has been demonstrated by clinical trials among several populations; howe...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
ScholarWorks
2016
|
| Subjects: | |
| Online Access: | https://scholarworks.waldenu.edu/dissertations/3151 https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=4254&context=dissertations |